Estimation of the α/β ratio of non-small cell lung cancer treated with stereotactic body radiotherapy
- 1 January 2020
- journal article
- research article
- Published by Elsevier in Radiotherapy and Oncology
- Vol. 142, 210-216
Abstract
No abstract availableKeywords
Funding Information
- Elekta
This publication has 26 references indexed in Scilit:
- In Vitro Radiobiological Advantages of Hypofractionation Compared with Conventional Fractionation: Early-Passage NSCLC Cells are Less Aggressive after HypofractionationRadiation Research, 2018
- Challenges in radiobiological modeling: can we decide between LQ and LQ-L models based on reviewed clinical NSCLC treatment outcome data?Radiation Oncology, 2016
- Radiobiology of hypofractionated stereotactic radiotherapy: what are the optimal fractionation schedules?Journal of Radiation Research, 2016
- High-dose and fractionation effects in stereotactic radiation therapy: Analysis of tumor control data from 2965 patientsRadiotherapy and Oncology, 2015
- The Tumor Radiobiology of SRS and SBRT: Are More Than the 5 Rs Involved?International Journal of Radiation Oncology - Biology - Physics (IJROBP), 2014
- Applicability of the linear-quadratic formalism for modeling local tumor control probability in high dose per fraction stereotactic body radiotherapy for early stage non-small cell lung cancerRadiotherapy and Oncology, 2013
- Abscopal Effects after Conventional and Stereotactic Lung Irradiation of Non–Small-Cell Lung CancerJournal of Thoracic Oncology, 2013
- A Generalized Linear-Quadratic Model for Radiosurgery, Stereotactic Body Radiation Therapy, and High–Dose Rate BrachytherapyScience Translational Medicine, 2010
- Some implications of linear‐quadratic‐linear radiation dose‐response with regard to hypofractionationMedical Physics, 2008
- Universal Survival Curve and Single Fraction Equivalent Dose: Useful Tools in Understanding Potency of Ablative RadiotherapyInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2008